Society guideline links: Fabry disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Heart failure in children" and "Society guideline links: Heart failure in adults" and "Society guideline links: Cardiomyopathy".)

International

●Fabry disease revisited – Management and treatment recommendations for adult patients (2018)

●Uncertain diagnosis of Fabry disease – Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance (2014)

United States

●National Society of Genetic Counselors (NSGC): Practice guidelines – Fabry disease (2020)

Europe

●European expert consensus statement on therapeutic goals in Fabry disease (2018)

●European Fabry Working Group: Consensus document – Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease (2015)

●Fabry Delphi Working Group: Delphi consensus on the current clinical and therapeutic knowledge on Anderson–Fabry disease (2014)